Full Text View
Tabular View
No Study Results Posted
Related Studies
Polysomnography Study of MK6096 in Patients With Primary Insomnia (6096-011)(COMPLETED)
This study has been completed.
Study NCT01021852   Information provided by Merck

First Received on November 25, 2009.   Last Updated on March 25, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Primary Insomnia
Additional conditions recognized in this trial
Sleep Initiation and Maintenance Disorders
More general conditions related to this trial
Dyssomnias
Mental Disorders
Nervous System Diseases
Sleep Disorders
Sleep Disorders, Intrinsic
Interventions listed in this trial
MK6096 2.5 mg and placebo
Comparator: MK6096 5 mg and placebo
Sponsors listed in this trial
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services